Drugs / MP-435
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01143337 | Jun 2010 → Mar 2012 | rheumatoid arthritis | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MP-435 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01143337 ↗ |